Accounts Receivable, after Allowance for Credit Loss, Current of Cosmos Health Inc. from 30 Jun 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Cosmos Health Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 30 Jun 2014 to 30 Sep 2025.
  • Cosmos Health Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $18,029,485, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Cosmos Health Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $18,029,485 +$545,245 +3.1% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $15,455,787 -$2,927,320 -16% 30 Jun 2025 10-Q 18 Aug 2025 2025 Q2
Q1 2025 $14,251,895 -$4,818,209 -25% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $13,478,263 -$6,280,991 -32% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $17,484,240 -$8,107,102 -32% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $18,383,107 -$5,185,023 -22% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $19,070,104 -$3,491,693 -15% 31 Mar 2024 10-Q 19 Aug 2024 2024 Q1
Q4 2023 $19,759,254 -$3,932,743 -17% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $25,591,342 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $23,568,130 30 Jun 2023 10-Q 15 Aug 2023 2023 Q2
Q1 2023 $22,561,797 31 Mar 2023 10-Q 16 May 2023 2023 Q1
Q4 2022 $23,691,997 31 Dec 2022 10-K 05 Aug 2024 2023 FY
Q3 2019 $5,782,135 +$4,164,324 +257% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $5,507,836 +$3,738,022 +211% 30 Jun 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 $5,569,831 +$3,334,851 +149% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 $4,753,291 +$3,497,695 +279% 31 Dec 2018 10-Q 14 Nov 2019 2019 Q3
Q3 2018 $1,617,811 -$1,240,707 -43% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 $1,769,814 -$312,757 -15% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $2,234,980 +$1,136,847 +104% 31 Mar 2018 10-Q 21 May 2018 2018 Q1
Q4 2017 $1,255,596 +$593,746 +90% 31 Dec 2017 10-K 18 Apr 2019 2018 FY
Q3 2017 $2,858,518 +$2,445,961 +593% 30 Sep 2017 10-Q 20 Nov 2017 2017 Q3
Q2 2017 $2,082,571 +$1,956,325 +1550% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 $1,098,133 +$1,002,647 +1050% 31 Mar 2017 10-Q 22 May 2017 2017 Q1
Q4 2016 $661,850 +$565,306 +586% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $412,557 30 Sep 2016 10-Q 17 Nov 2016 2016 Q3
Q2 2016 $126,246 30 Jun 2016 10-Q 18 Aug 2016 2016 Q2
Q1 2016 $95,486 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $96,544 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q3 2014 $62,030 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 $1,228,050 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.